Cytosorbents (CTSO) EBT Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly EBT Margin came in at 124.55% in Q1 2026, down 10761.0% YoY from N/an in Q1 2025, and down 109.22% on a QoQ basis from 59.53% in Q4 2025.
Cytosorbents (CTSO) EBT Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of EBT Margin data on file, last reported at 124.55% in Q1 2026.
- Quarterly EBT Margin fell 10761.0% year-over-year to 124.55% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 121.83% (down 10463.0% YoY) and the FY2025 annual result came in at 23.2%, up 682.0% from the prior year.
- EBT Margin declined to 124.55% in Q1 2026, from 59.53% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 26.94% in Q4 2024 to a low of 262.17% in Q2 2025.
- A 5-year average of 79.75% and a median of 70.07% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin surged 10710 bps — and 2025, when it slumped 21359 bps.
- Tracing CTSO's EBT Margin over 5 years: stood at 19.79% in 2022, then plunged by 305 bps to 80.16% in 2023, then surged by 134 bps to 26.94% in 2024, then slumped by 321 bps to 59.53% in 2025, then slumped by 109 bps to 124.55% in 2026.
- The last three EBT Margin figures came in at 124.55% (Q1 2026), 59.53% (Q4 2025), and 37.65% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.32% |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -36.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -233.78% |
| Mar 31, 2026 | -124.55% |
| Dec 31, 2025 | -59.53% |
| Sep 30, 2025 | -37.65% |
| Jun 30, 2025 | -262.17% |
| Mar 31, 2025 | -16.94% |
| Dec 31, 2024 | 26.94% |
| Sep 30, 2024 | -32.14% |
| Jun 30, 2024 | -48.58% |
| Mar 31, 2024 | -67.73% |
| Dec 31, 2023 | -80.16% |
| Sep 30, 2023 | -104.28% |
| Jun 30, 2023 | -70.07% |
| Mar 31, 2023 | -77.49% |
| Dec 31, 2022 | -19.79% |
| Sep 30, 2022 | -150.42% |
| Jun 30, 2022 | -128.06% |
| Mar 31, 2022 | -103.16% |
| Dec 31, 2021 | -93.14% |
| Sep 30, 2021 | -65.64% |